Today, Intercept Pharmaceuticals (ICPT) – Research Analysts’ Recent Ratings Updates

Today, Intercept Pharmaceuticals (ICPT) – Research Analysts’ Recent Ratings Updates

Intercept Pharmaceuticals (NASDAQ: ICPT) has recently received a number of price target changes and ratings updates:

Shares of Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) opened at 108.71 on Tuesday. The stock’s 50 day moving average price is $122.88 and its 200-day moving average price is $145.74. Intercept Pharmaceuticals Inc. has a 52-week low of $89.76 and a 52-week high of $179.61. The company’s market capitalization is $2.70 billion.

Intercept Pharmaceuticals (NASDAQ:ICPT) last posted its quarterly earnings data on Thursday, November 3rd. The biopharmaceutical company reported ($3.59) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($3.82) by $0.23. The business earned $4.70 million during the quarter, compared to the consensus estimate of $4.77 million. Intercept Pharmaceuticals had a negative return on equity of 66.97% and a negative net margin of 3,287.95%. Intercept Pharmaceuticals’s quarterly revenue was up 1051.1% on a year-over-year basis. During the same period last year, the company earned ($2.10) earnings per share. On average, analysts expect that Intercept Pharmaceuticals Inc. will post ($15.63) earnings per share for the current year.

Related posts

Leave a Comment